Gene · 2829
NIH grants1,173
NIH grants whose papers are about the gene, through NIH's grant-paper links.
481 to 500 of 1,173
Download this page as JSON| Grant | Title | XCR1 papers | Newest fiscal year |
|---|---|---|---|
| ZIABC010750 | Heterodimeric IL-15 in Cancer Immunotherapy | 2 | 2022 |
| DP1AI144248 | Quantifying Cell-Cell Interactions in the Immune System by Trans-Synaptic Labeling | 1 | 2022 |
| F30CA247020 | Targeting Heme Metabolism for the Treatment of KRAS- KEAP1-Mutant Lung Adenocarcinoma | 1 | 2022 |
| F30HG011194 | Experimental and Computational Methods for Scaling-up Transcriptome Analyses and Improving Disease Risk Predictions | 1 | 2022 |
| F32CA239362 | Cytosolic Delivery of Tumor Antigens into Dendritic Cells | 1 | 2022 |
| I01BX001444 | Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant | 1 | 2022 |
| K01DE027087 | IFI16 is a Periodontitis Modulating Protein | 1 | 2022 |
| K08CA230213 | Investigating L1CAM-dependent stem cell regeneration in metastasis | 1 | 2022 |
| K08HL141601 | Clinical significance and genetic determinants of novel imaging measures of emphysema distribution in 9,743 smokers | 1 | 2022 |
| K22AI143960 | Regulation of T cell ligand discrimination by tuning the phosphorylation kinetics of Zap70 substrates | 1 | 2022 |
| KL2TR002490 | North Carolina Translational and Clinical Science Institute (NC TraCS) KL2 | 1 | 2022 |
| P01CA129243 | Targets for Therapy for Carcinomas of the Lung | 1 | 2022 |
| P01CA210944 | Radiation and checkpoint blockade for cancer immune therapy | 1 | 2022 |
| P20GM103648 | Oklahoma Center for Respiratory and Infectious Diseases | 1 | 2022 |
| R00CA226679 | Defining the Role of Metabolic Heterogeneity in Melanoma Dissemination and Therapy Escape | 1 | 2022 |
| R01AG057777 | MENDELIAN RANDOMIZATION FOR UNBIAS BIOMARKER DISCOVERY FOR AD AND OTHER COMPLEX TRAITS | 1 | 2022 |
| R01AI030048 | T cell Memory to Viruses | 1 | 2022 |
| R01AI033144 | The Immunogenetics of Measles Immunity | 1 | 2022 |
| R01AI040618 | Lung-Resident Memory Th2 cells in Asthma - New Therapeutic Targets | 1 | 2022 |
| R01AI072117 | Regulation of T cell immunity to viral infection | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2829/grants?page=25